Skip to main content

Cancer Center members contribute to the mission of the Center via their participation in research, including laboratory, clinical, and population-based efforts.

Nuclear Control of Cell Growth and Differentiation

Cell Response and Regulation

Experimental Therapeutics

Cancer Control and Population Sciences

The four programs drive progress at our National Cancer Institute-designated Comprehensive Cancer Center by:

  • Providing a forum to highlight important new developments and opportunities in cancer research
  • Supporting creative project development and new collaborative initiatives
  • Emphasizing the tremendous unmet medical needs in cancer
  • Stimulating our talented researchers to focus on these needs

Cancer Center Membership

HCI Cancer Center members enjoy a variety of benefits, including eligibility for leadership roles in the Center, institutional funding opportunities, and scientific/administrative support.

Cancer Center Director

Cornelia Ulrich, MS, PhD

HCI Senior Directors

Neeraj Agarwal, MD
Clinical Research Innovation
Donald E. Ayer, PhD
Cancer Training and Career Enhancement
Rachel Ceballos, PhD
Community Outreach and Engagement
Max Loveless, MBA
Senior Administrative Director
Martin McMahon, PhD
Preclinical Translation
Kolawole S. Okuyemi, MD, MPH
Equity, Diversity, and Inclusion
Tracy Onega, PhD, MS
Population Sciences
Aik Choon Tan, PhD
Data Science
Alana Welm, PhD
Basic Science
Theresa Werner, MD
Clinical Research
David Wetter, PhD, MS
Cancer Health Equity Science

Program Leadership

Nuclear Control of Cell Growth and Differentiation

Jay Gertz, PhD
Co-Leader
Jared Rutter, PhD
Co-Leader

Cell Response and Regulation

Sheri Holmen, PhD
Leader

Experimental Therapeutics

Howard Colman, MD, PhD
Co-Leader
Martin McMahon, PhD
Co-Leader

Cancer Control and Population Sciences

Jennifer Doherty, MS, PhD
Co-Leader
Kathleen Mooney, PhD
Co-Leader